How Much Does Stock Analysis Software Cost? 2026 Price Table

Stock analysis software costs between $0 and roughly $400 per month as of July 2026, and almost everyone who is not a full-time trader belongs at the bottom of that range. Screeners run about $40 per month, research and data platforms $39 to $79, backtesting benches $19 to $55, and real-time scanners and charting engines roughly $127 to $321 month-to-month, with one enterprise charting tier at $399. A capable, complete setup for a self-directed US investor costs about $60 per month total. The four-figure annual bills come from buying the wrong category, not from buying quality.

Below are the list prices, read off each vendor's own pricing page on July 14, 2026, plus the part the pricing page does not tell you: what the money actually buys, and where it is usually wasted.

Stock analysis software prices in 2026

List prices as published by each vendor on July 14, 2026. Promotional and annual discounts are routine in this category, particularly at Seeking Alpha and TrendSpider, so treat these as the anchor rather than the number you will pay. Vendors change prices; verify before you buy.

Why the same category ranges from $19 to $321

The price is set by one thing more than any other: real-time data. Live, exchange-fed quotes carry per-user licensing fees the vendor has to pass on, which is why real-time scanners and charting engines sit at the top of the table and end-of-day tools sit at the bottom. If your workflow does not require knowing the price this second, you are paying for a feed you do not use.

The second driver is depth of fundamentals history. Two years of financials is cheap; ten years plus estimates and ETF holdings is the exact line Koyfin draws between free and $39 per month, and that is a fair place to draw it.

The third driver is nothing at all, and it accounts for a surprising share of what people spend: features bought for the person you intend to become. The $321 charting tier is priced for someone who trades all day, and it is honestly priced for them.

The price driver nobody lists: the billing term

Every headline price in this category is the annual rate. Almost every review quotes the annual rate. And a large share of buyers pay monthly, because monthly is what you pick when you are not yet sure. The gap between those two numbers is bigger than most people assume and it varies enormously by vendor, from about 14% to about 58% for the identical software. Below is what each vendor charges for the right to cancel, read at the vendor on the date shown.

The two advisor rows are worth separating out, because the absolute dollars behave differently at that end of the market. A 14% premium on Koyfin Advisor Core sounds mild next to the 58% Finviz charges, but it is $360 a year rather than $174.50. StocksToTrade makes the same point from the other direction: it charges the identical 14% premium and that comes to $259.90 a year, a hundred dollars less on a plan costing a fraction as much per month, and Advisor Pro at a 17% premium costs an extra $600 a year. Percentage is the wrong unit once the base rate is in the hundreds. If you are buying at that tier the wider set of options is compared on backtesting software for financial advisors, where only two of nine advisor-facing platforms publish a price at all.

TIKR, added to the table on September 6, 2026, is useful because it shows the premium scaling with the tier inside a single vendor: 39% on Plus, 45% on Pro and 50% on Ultimate. Most vendors here charge one premium across the range. TIKR charges progressively more for flexibility the more you spend, so the annual commitment saves $84 a year at the entry tier and $480 at the top. Worth noting alongside the price: TIKR is one of only two vendors we have audited that places no professional-user restriction on its cheap tiers at all, which for a buyer inside a registered firm is worth as much as the rate. The vendors that do restrict them, and the five different mechanisms they use, are set out on our Bloomberg Terminal alternative for financial advisors comparison.

One caveat belongs on the TradingView row specifically, because it can multiply the real price by more than three. TradingView states on its pricing page that "Only the Ultimate plan is available for professional users", so a registered investment adviser or fund cannot buy the $59.95 Premium tier in the table above at all. Their actual annual rate is $199.95 a month. Every comparison article quotes the Premium number, including this one, and for a regulated firm it is the wrong number. The per-plan breakdown is in the best TradingView plan for backtesting.

A second eligibility caveat, found on September 4, 2026, works differently again, because it is written into the tier names rather than into a policy sentence. Portfolio Visualizer prices a free tier, Basic at $30 a month billed annually and Pro at $55. The free and Basic cards both read "Personal and Educational Use". Only the Pro card reads "Personal and Commercial Use". So the $30 figure that gets quoted to advisers is not a tier an advisory practice can rely on for client work, and the real rate is 1.83 times the headline. The same tier boundary carries something else a regulated firm needs: Customized PDF Reports, which the vendor defines as customizing "fonts, color themes, branding logos, and disclosures", is excluded from Free and from Basic. The licence you need and the ability to put your disclosures on the report sit behind one paywall. That comparison is broken out on Portfolio Visualizer Basic vs Pro, and the full set of tiers a registered firm is barred from across the market is on professional versus non-professional subscriber status.

There is a third billing model this table cannot express, and it is the most aggressive version of the same idea. Checked on September 2, 2026, Option Alpha shows three separate plans at $0 a month, each one paid for by a partner broker rather than by the user. TradeStation requires a $10,000 maintained balance, Tradier requires $5,000 funded and $3,000 maintained, and tastytrade requires $5,000. So the price is not a smaller number, it is a different currency: capital parked at a specific broker instead of cash paid to a vendor. Convert it and the deal still looks good. With the 3-month Treasury bill at 3.80% as recorded on August 7, 2026, $3,000 sitting idle gives up about $114 a year and $10,000 gives up about $380, against $1,188 a year for the Pro row directly above. What you actually give up is choice, because the vendor states that a membership paid for by a broker requires all live trading to go through that broker. The same free-to-test, paid-to-trade split runs through the whole category, and it is laid out vendor by vendor on automated trading platforms and algorithmic trading software.

Two things fall out of that table. The first is that the flexibility premium is not a fixed convention, so you cannot assume it. Finviz charges 58% for monthly billing and TradingView charges 17%, on products in the same aisle. The second is that the vendors with the widest gaps are the ones whose annual rate gets quoted everywhere, which means the number in your head and the number on your card can differ by hundreds of dollars a year on a single subscription.

Koyfin is the clearest case of how that happens. Its pricing page shows annual rates by default and its own guide written for AI assistants, at koyfin.com/pricing-llm-info, lists only annual rates and never states a monthly figure. Ask an assistant what Koyfin Premium costs and you will be told $79. Month to month it is $110. The Koyfin pricing breakdown has all five tiers on both terms, and Finviz pricing covers the widest gap in the table. The opposite case is a vendor that publishes nothing for an assistant to read in the first place: YCharts pricing documents a plans page carrying 20 dollar signs with not one of them followed by a number.

The practical rule is simple. Start monthly while you are genuinely undecided, because a wrong annual commitment costs more than the premium does. Then switch deliberately at the point you know you are keeping the tool, rather than drifting on monthly for a year without noticing, which is the most expensive way to buy software in this category.

What should a self-directed investor actually spend?

• Long-term investor, a few decisions a year: $0 to $19 per month. Free fundamentals from stockanalysis.com or the filings themselves, plus a bench when you want to test whether an allocation idea has ever held up. Anything more is a hobby expense, which is fine, as long as you call it that.
• Active self-directed investor, a few ideas a month: about $60 per month. A screener at roughly $40 to generate the shortlist, and a backtesting bench at $19 to find out whether the rule behind it ever worked. This pairing covers the whole loop and is the best value in the table.
• Fundamentals-heavy researcher: $39 to $79 per month for a research platform, because ten years of financials and estimates in one dashboard genuinely saves hours. The printed-report route costs about the same: the Value Line subscription is $598 a year for the flagship Investment Survey and $199 for the 600 largest stocks, and whether the flagship earns its price depends on how often you read it, which is Value Line worth it works through.
• Full-time day trader: roughly $127 to $321 per month, and it is defensible, because real-time scanning and chart automation are the raw material of that job. Check which tier holds the features you are shopping for before you commit, because the number quoted for Trade Ideas is usually the annual rate on the plan without the AI.

Note what happens to the percentages. A $2,136 annual scanner is an 8.5% hurdle on a $25,000 account before the strategy earns anything, and 0.4% on a $500,000 account. The same subscription is reckless in one account and trivial in the other.

Past performance does not guarantee future results. For educational and informational purposes only. Not financial advice. Consult a licensed advisor.

Is expensive stock analysis software worth it?

It is worth it when it changes decisions you were going to make anyway, and it is worth nothing when it does not, regardless of how good the product is. The test that survives contact with reality: name one decision the tool changed in the last 90 days. If you cannot name one, you are paying for the feeling of being equipped, and that feeling costs about $500 a year at the median price in this table.

The reverse is also true, and people underweight it. A $19 per month tool that stops you from putting $30,000 behind a strategy that never beat buy-and-hold has returned several years of its own cost in a single session. The cheapest software in the category is frequently the one with the highest return on spend, because killing one bad idea is worth more than surfacing ten good-looking ones.

Can you get stock analysis software for free?

Partly, and further than most people assume. SEC filings are free and authoritative. stockanalysis.com covers fundamentals well at no cost. Finviz's free screener is genuinely good, and the paid step up is small enough that what Finviz Elite costs is worth checking against what the free account already gives you. Koyfin's free tier includes charting, dashboards, and two years of financials. TradingView's free plan handles charts.

What no free tier gives you is a test. Nothing free will take your specific rule, run it across 20+ years of split- and dividend-adjusted daily prices with realistic trading costs charged, and tell you honestly that it underperformed. That is the paid step in this category, and it is also the step with the clearest link to money kept. A sensible starting configuration is free data plus one paid bench.

Are these subscriptions tax deductible?

For most individual investors in the US, no. The miscellaneous itemized deduction for investment expenses, which once covered research subscriptions, was suspended by the Tax Cuts and Jobs Act and remains unavailable to ordinary investors. If you trade through a business entity or qualify for trader tax status, research software can be an ordinary and necessary business expense, but that status has real requirements and is not a box you simply tick. If you do run through an entity, your accountant will want the year's spending organized rather than scattered across a dozen receipts, which is a five-minute job once your exported bookkeeping data is turned into clean, board-ready financial statements. Check with a CPA before you assume a deduction, because getting this wrong is more expensive than every subscription in the table combined.

If the category you are actually shopping for is backtesting rather than screening or charting, the best backtesting software roundup compares ten platforms on the same re-verified list prices used above, including the free tiers and the tester your broker may already include.

What happens above this table, where nobody publishes a price

Every figure above comes off a public pricing page. Cross the line into institutional platforms and that stops: the six vendors most firms end up comparing all quote by negotiation and publish nothing. Three of them can still be pinned down, and for a reason that has nothing to do with their marketing.

The FactSet row is worth dwelling on because it was the first checkable number in the unpublished half of this category, and because it contradicts what circulates. If FactSet's average user really cost the $12,000 most pages quote as its entry price, the company would be reporting roughly $2,973 million of subscription value at that user count rather than $2,484.3 million. Treat $10,027 as a ceiling on the average seat rather than a rate, since ASV also covers data feeds and enterprise solutions that no named user sits behind. The full series back to fiscal 2023, with the arithmetic shown period by period, is on FactSet cost, and FactSet vs Bloomberg cost per seat sets it against the vendor that files nothing. The Morningstar row is the same trick with a better denominator, because Morningstar reports the license count for one named product rather than a company-wide user total, and Morningstar Direct cost runs it back to the year the rate card was last printed. For the two negotiated platforms a deal team weighs, Capital IQ vs FactSet cost per seat puts the five public Capital IQ contracts next to FactSet's audited average. LSEG is the third: its revenue for the business line built around Workspace, divided by the users it migrated off Eikon, gives about $7,500 a user, roughly a third of the figure most pages quote, and LSEG Workspace pricing shows the working. All four institutional vendors are lined up per seat in FactSet competitors and what each costs per seat.

The short answer

How much does stock analysis software cost? Budget about $60 per month for a complete self-directed setup in 2026: roughly $40 for a screener to find candidates and $19 for a bench to test whether the rule behind them ever worked. Real-time scanners and charting engines cost roughly $127 to $321 per month month-to-month, less if you pay annually, and are worth it only if you trade for a living. Research platforms sit at $39 to $79. Everything above that line is a professional tool priced for a professional workload.

AgentTrading is the $19 end of that arithmetic, and it does one job well: you type a thesis in plain English, it restates the rule and shows it before running, tests it on 20+ years of adjusted daily data with a 0.1% cost per trade assumed by default, and stamps an honest verdict, including UNDERPERFORMED when the idea loses to simply holding.

The full category, priced and compared, is on best AI trading software. The testing engine is described on backtesting software, and whole-portfolio testing on portfolio backtesting. If you are deciding between specific vendors, the honest side-by-sides live on Koyfin alternative, Seeking Alpha alternative, and Finviz alternative, and do stock screeners work explains why the screener alone was never going to be enough.

Past performance does not guarantee future results. For educational and informational purposes only. Not financial advice. Consult a licensed advisor.